BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 21045237)

  • 1. CDKN1B/p27 expression in peripheral T cell lymphoma not otherwise specified.
    Gazzola A; Sista MT; Agostinelli C; Righi S; Sapienza MR; Mannu C; Rossi M; Bacci F; Sabattini E; Went P; Zinzani PL; Pileri SA; Piccaluga PP
    J Clin Pathol; 2011 Jan; 64(1):83-7. PubMed ID: 21045237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High resolution SNP array genomic profiling of peripheral T cell lymphomas, not otherwise specified, identifies a subgroup with chromosomal aberrations affecting the REL locus.
    Hartmann S; Gesk S; Scholtysik R; Kreuz M; Bug S; Vater I; Döring C; Cogliatti S; Parrens M; Merlio JP; Kwiecinska A; Porwit A; Piccaluga PP; Pileri S; Hoefler G; Küppers R; Siebert R; Hansmann ML
    Br J Haematol; 2010 Feb; 148(3):402-12. PubMed ID: 19863542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classification of distinct subtypes of peripheral T-cell lymphoma unspecified, identified by chemokine and chemokine receptor expression: Analysis of prognosis.
    Ohshima K; Karube K; Kawano R; Tsuchiya T; Suefuji H; Yamaguchi T; Suzumiya J; Kikuchii M
    Int J Oncol; 2004 Sep; 25(3):605-13. PubMed ID: 15289861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of FoxP3 expression in peripheral T-cell lymphoma.
    Bonzheim I; Geissinger E; Tinguely M; Roth S; Grieb T; Reimer P; Wilhelm M; Rosenwald A; Müller-Hermelink HK; Rüdiger T
    Am J Clin Pathol; 2008 Oct; 130(4):613-9. PubMed ID: 18794055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation.
    Piccaluga PP; Agostinelli C; Califano A; Carbone A; Fantoni L; Ferrari S; Gazzola A; Gloghini A; Righi S; Rossi M; Tagliafico E; Zinzani PL; Zupo S; Baccarani M; Pileri SA
    Cancer Res; 2007 Nov; 67(22):10703-10. PubMed ID: 18006812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral T-cell lymphoma gene expression profiles.
    Martinez-Delgado B
    Hematol Oncol; 2006 Sep; 24(3):113-9. PubMed ID: 16676369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Forkhead box P1 overexpression and its clinicopathologic significance in peripheral T-cell lymphoma, not otherwise specified.
    Yamada S; Sato F; Xia H; Takino H; Kominato S; Ri M; Ishida T; Iida S; Inagaki H; Yamada K
    Hum Pathol; 2012 Aug; 43(8):1322-7. PubMed ID: 22401769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified.
    Laginestra MA; Piccaluga PP; Fuligni F; Rossi M; Agostinelli C; Righi S; Sapienza MR; Motta G; Gazzola A; Mannu C; Sabattini E; Bacci F; Tabanelli V; Sacchetti CA; Barrese TZ; Etebari M; Melle F; Clò A; Gibellini D; Tripodo C; Inghirami G; Croce CM; Pileri SA
    Blood Cancer J; 2014 Nov; 4(11):259. PubMed ID: 25382608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of nm23-H1 is associated with poor prognosis in peripheral T-cell lymphoma, not otherwise specified.
    Niitsu N; Nakamine H; Okamoto M
    Clin Cancer Res; 2011 May; 17(9):2893-9. PubMed ID: 21478336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets.
    Piccaluga PP; Agostinelli C; Califano A; Rossi M; Basso K; Zupo S; Went P; Klein U; Zinzani PL; Baccarani M; Dalla Favera R; Pileri SA
    J Clin Invest; 2007 Mar; 117(3):823-34. PubMed ID: 17304354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression profiling of microRNA and their target genes in peripheral T cell lymphoma, not otherwise specified].
    Li M; Lü N; Liu HX; Chen DB; Zhang JZ
    Zhonghua Bing Li Xue Za Zhi; 2013 Aug; 42(8):519-24. PubMed ID: 24246916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study.
    Piccaluga PP; Fuligni F; De Leo A; Bertuzzi C; Rossi M; Bacci F; Sabattini E; Agostinelli C; Gazzola A; Laginestra MA; Mannu C; Sapienza MR; Hartmann S; Hansmann ML; Piva R; Iqbal J; Chan JC; Weisenburger D; Vose JM; Bellei M; Federico M; Inghirami G; Zinzani PL; Pileri SA
    J Clin Oncol; 2013 Aug; 31(24):3019-25. PubMed ID: 23857971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression and clinical significance of nm23-H1 and MUC-1 in peripheral T-cell lymphoma].
    Huang HQ; Pan ZH; Lin XB; Wang BF; Hou JH; Zhang Y; Wu QL
    Ai Zheng; 2006 Dec; 25(12):1517-23. PubMed ID: 17166378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in the understanding and management of angioimmunoblastic T-cell lymphoma.
    de Leval L; Gisselbrecht C; Gaulard P
    Br J Haematol; 2010 Mar; 148(5):673-89. PubMed ID: 19961485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of master regulators of helper T-cell differentiation in peripheral T-cell lymphoma, not otherwise specified, by immunohistochemical analysis.
    Matsumoto Y; Horiike S; Ohshiro M; Yamamoto M; Sasaki N; Tsutsumi Y; Kobayashi T; Shimizu D; Uchiyama H; Kuroda J; Nomura K; Shimazaki C; Taniwaki M
    Am J Clin Pathol; 2010 Feb; 133(2):281-90. PubMed ID: 20093238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression levels of NF-Y target genes changed by CDKN1B correlate with clinical prognosis in multiple cancers.
    Yamanaka K; Mizuarai S; Eguchi T; Itadani H; Hirai H; Kotani H
    Genomics; 2009 Oct; 94(4):219-27. PubMed ID: 19559782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Array comparative genomic hybridization analysis of PTCL-U reveals a distinct subgroup with genetic alterations similar to lymphoma-type adult T-cell leukemia/lymphoma.
    Nakagawa M; Nakagawa-Oshiro A; Karnan S; Tagawa H; Utsunomiya A; Nakamura S; Takeuchi I; Ohshima K; Seto M
    Clin Cancer Res; 2009 Jan; 15(1):30-8. PubMed ID: 19118030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic profiling identifies outcome-predictive markers in patients with peripheral T-cell lymphoma, not otherwise specified.
    Ludvigsen M; Bjerregård Pedersen M; Lystlund Lauridsen K; Svenstrup Poulsen T; Hamilton-Dutoit SJ; Besenbacher S; Bendix K; Møller MB; Nørgaard P; d'Amore F; Honoré B
    Blood Adv; 2018 Oct; 2(19):2533-2542. PubMed ID: 30291111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The spectrum of peripheral T-cell lymphomas.
    O'leary H; Savage KJ
    Curr Opin Hematol; 2009 Jul; 16(4):292-8. PubMed ID: 19509496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus negative clonal plasma cell proliferations and lymphomas in peripheral T-cell lymphomas: a phenomenon with distinctive clinicopathologic features.
    Balagué O; Martínez A; Colomo L; Roselló E; Garcia A; Martínez-Bernal M; Palacín A; Fu K; Weisenburger D; Colomer D; Burke JS; Warnke RA; Campo E
    Am J Surg Pathol; 2007 Sep; 31(9):1310-22. PubMed ID: 17721185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.